Literature DB >> 16759721

A case of fatal stent thrombosis after Carbostent implantation: is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy?

Giampaolo Niccoli, Massimo Siviglia, Maria De Vita, Luca Altamura, Beatrice Fusco, Antonio Maria Leone, Giuseppe Ferrante, Antonio G Rebuzzi, Filippo Crea.   

Abstract

We describe a case of fatal stent thrombosis after Carbostent implantation and clopidogrel alone antiplatelet therapy in a patient affected by rectal cancer who does not tolerate aspirin. He had three-vessel disease, with occlusion of the right and left anterior descending coronary artery and a severe stenosis of the proximal left circumflex. High-risk circumflex percutaneous coronary intervention (PCI) was performed under left ventricular assistance by Impella device with an optimal final angiographic result. After 2 h, however, the patient developed chest pain with marked ST segment elevation in the infero-lateral leads, due to stent thrombosis, and hypotention which rapidly degenerated into cardiac arrest, electromechanical dissociation and death. At the present time the choice between PCI at high risk of stent thrombosis followed by low risk cancer resection and cancer resection at high risk of peri-operative myocardial infarction followed by low risk PCI remains difficult.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759721     DOI: 10.1016/j.ijcard.2005.11.079

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Sirolimus-eluting stents versus bare-metal stents in routine clinical use: a nonrandomized comparison.

Authors:  Muhammad Munir; Jonathan Aliota; Amany Ahmed; Anwarullah Mohammed; Vei Vei Lee; Macarthur A Elayda; James M Wilson
Journal:  Tex Heart Inst J       Date:  2011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.